Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2801 - 2808 of 12062 results

Life Sciences CEO Interview: Joe Payne, President and CEO of Arcturus Therapeutics
November 1, 2021| Blog| Viewpoint

Roller Derby Team Ups Heat in Cleveland Guardians Trademark Fight
October 29, 2021| News

Antitrust Agencies to Hold Virtual Public Workshop to Promote Competition in Labor Markets
October 29, 2021| Blog| Viewpoint

EEOC Updates Religious Accommodation and Vaccine Mandate Guidance
October 28, 2021| Blog| Viewpoint

Cleveland Team Sued by Roller Derby Team Over Guardians Name Change
October 28, 2021| News

Webinar Recording: Current and Upcoming Changes to Immigration Processes
October 28, 2021| Webinar| Viewpoint

Federal Circuit Clarifies that Willful Infringement Does Not Require Egregious Conduct
October 26, 2021| Blog| Viewpoint
News & Press Releases
Mintz Advises PHLUR on Acquisition by TSG Consumer
July 29, 2025
Mintz advised PHLUR, a modern fragrance brand recognized for its emotion-led storytelling and accessible positioning, in its acquisition by TSG Consumer, a leading private equity firm specializing in consumer brands.
Mintz Attorneys Named to Los Angeles Business Journal’s 2025 “Leaders of Influence: Litigators & Trial Attorneys” List
July 28, 2025
Mintz Member Esteban Moralesand Special Counsel Nada Shamonki has been recognized by Los Angeles Business Journal in its 2025 “Leaders of Influence: Litigators & Trial Attorneys” list which recognizes lawyers who “go to the proverbial mat to fight for their clients,” according to the publication.
Is Biopharma M&A In a Holding Pattern or a ‘New Normal’
July 23, 2025
Life Sciences International Chair Cheryl Reicin recently joined the Scrip M&A Podcast to share insights on the evolving landscape of biopharmaceutical mergers and acquisitions. In the episode, Cheryl highlights an uptick in pre-M&A activity, as major pharmaceutical companies increasingly leverage license and option agreements to strengthen their pipelines and product portfolios while positioning themselves for potential future acquisitions.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
